Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07323888 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Traditional vs. Posterior Nasal Radiofrequency Ablation for Chronic Rhinitis

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status changed: Not Yet Recruiting → Active, Not Recruitingv4 Show 4 more changesShow less
    • Primary completion pushed from Dec 2026 to Apr 5, 2027
    • Study completion moved earlier from Dec 2027 to May 1, 2027
    • Start date changed from estimate of Jan 2026 to Mar 1, 2026
    • Site contact updated
  2. Site contact updatedv3
  3. Lead sponsor: En-Ying Wang to Chien Yu Huangv2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is a prospective, single-center, single-blinded randomized controlled trial designed to compare the clinical effectiveness of traditional radiofrequency ablation of the anterior inferior turbinate alone versus expanded radiofrequency ablation including the middle and posterior portions of the inferior turbinate (posterior nasal region). Patients with chronic rhinitis who remain symptomatic despite at least six months of medical therapy will be randomized in a 2:1 ratio to undergo extended posterior nasal ablation versus traditional anterior treatment. Symptom improvement will be evaluated using rTNSS and other validated questionnaires.
Trial Details
NCT Number NCT07323888
Lead Sponsor Chien Yu Huang
Conditions
(from sponsor)		 Nasal Obstruction, Chronic Rhinitis, Nonallergic Rhinitis, Rhinorrhea, Inferior Turbinate Hypertrophy
Related terms Nasal Obstruction, Rhinorrhea
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov